Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

NCT01066715 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT01066715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2011
Enrollment
421 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus